NFκB and glucocorticoid receptor activity in steroid resistance

References

• Cupps TR, Fauci AS. Corticosteroid-mediated immunoregulation in man. Immunol Rev 1982, 65, 133–155.
   PubMed Web of Science ®Google Scholar
• Wrange O, Eriksson P, Perlmann T. The purified activated glucocorticoid receptor is a homodimer. J Biol Chem 1989, 264, 5253–5259.
   PubMed Web of Science ®Google Scholar
• Novac N, Baus D, Dostert A, Heinzel T. Competition between glucocorticoid receptor and NFκB for control of the human FasL promoter. FASEB J 2006, 20, 1074–1081.
   PubMed Web of Science ®Google Scholar
• Malkoski SP, Dorin RI. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol Endocrinol 1999, 13, 1629–1644.
   PubMed Web of Science ®Google Scholar
• Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994, 91, 752–756.
   PubMed Web of Science ®Google Scholar
• Nissen RM, Yamamoto KR. The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 2000, 14, 2314–2329.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: Importance in inflammatory lung diseases. Eur Respir J 2005, 25, 552–563.
   PubMed Web of Science ®Google Scholar
• Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000, 20, 6891–6903.
   PubMed Web of Science ®Google Scholar
• Ayroldi E, Migliorati G, Bruscoli S, Marchetti C, Zollo O, Cannarile L, D’Adamio F, Riccardi C. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor κB. Blood 2001, 98, 743–753.
   PubMed Web of Science ®Google Scholar
• D’Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A, Cannarile L, Migliorati G, Riccardi C. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 1997, 7, 803–812.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J 2006, 27, 413–426.
   PubMed Web of Science ®Google Scholar
• Clark AR. MAP kinase phosphatase 1: A novel mediator of biological effects of glucocorticoids? J Endocrinol 2003, 178, 5–12.
   PubMed Web of Science ®Google Scholar
• Yamamoto KR. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 1985, 19, 209–252.
   PubMed Web of Science ®Google Scholar
• Healey LA, Sheets PK. The relation of polymyalgia rheumatica to rheumatoid arthritis. J Rheumatol 1988, 15, 750–752.
   PubMed Web of Science ®Google Scholar
• van Schaardenburg D, Valkema R, Dijkmans BA, Papapoulos S, Zwinderman AH, Han KH, Pauwels EK, Breedveld FC. Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment. Arthritis Rheum 1995, 38, 334–342.
   PubMed Web of Science ®Google Scholar
• Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J, Takasaki Y, Hashimoto H. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Arthritis Rheum 1988, 41, 823–830.
   Google Scholar
• Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, Jewell DP. Predicting outcome in severe ulcerative colitis. Gut 1996, 38, 905–910.
   PubMed Web of Science ®Google Scholar
• Hearing SD, Norman M, Smyth C, Foy C, Dayan CM. Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab 1999, 84, 4149–4154.
   PubMed Web of Science ®Google Scholar
• Lane SJ, Arm JP, Staynov DZ, Lee TH. Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma. Am J Respir Cell Mol Biol 1994, 11, 42–48.
   PubMed Web of Science ®Google Scholar
• Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ, Adcock I, Chung KF. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006, 174, 134–141.
   PubMed Web of Science ®Google Scholar
• Corrigan CJ, Brown PH, Barnes NC, Tsai JJ, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 1991, 144, 1026–1032.
   PubMedGoogle Scholar
• Leung DY, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 1995, 181, 33–40.
   PubMed Web of Science ®Google Scholar
• Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma. J Allergy Clin Immunol 2002, 109, 649–657.
   PubMed Web of Science ®Google Scholar
• Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I, Chung KF. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 2008, 63, 784–790.
   PubMed Web of Science ®Google Scholar
• Adcock IM, Lane SJ, Brown CR, Lee TH, Barnes PJ. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med 1995, 182, 1951–1958.
   PubMed Web of Science ®Google Scholar
• Onda K, Rimbara E, Hirano T, Oka K, Abe H, Tahara K, Takanashi H, Tsuboi N, Niitsuma T, Hayashi T. Role of mRNA expression of transcription factors in glucocorticoid sensitivity of peripheral blood mononuclear cells and disease state in rheumatoid arthritis. J Rheumatol 2004, 31, 464–469.
   PubMed Web of Science ®Google Scholar
• Ismaili N, Garabedian MJ. Modulation of glucocorticoid receptor function via phosphorylation. Ann N Y Acad Sci 2004, 1024, 86–101.
   PubMed Web of Science ®Google Scholar
• Hearing SD, Norman M, Probert CS, Haslam N, Dayan CM. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 1999, 45, 382–388.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009, 373, 1905–1917.
   PubMed Web of Science ®Google Scholar
• Grant IW. Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients. Clin Sci 1984, 67, 639–645.
   Web of Science ®Google Scholar
• Hermoso MA, Matsuguchi T, Smoak K, Cidlowski JA. Glucocorticoids and tumor necrosis factor α cooperatively regulate toll-like receptor 2 gene expression. Mol Cell Biol 2004, 24, 4743–4756.
   PubMed Web of Science ®Google Scholar
• Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O’Shea JJ, Chrousos GP, Bornstein SR. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002, 16, 61–71.
   PubMed Web of Science ®Google Scholar
• McKay LI, Cidlowski JA. Cross-talk between nuclear factor-κB and the steroid hormone receptors: Mechanisms of mutual antagonism. Mol Endocrinol 1998, 12, 45–56.
   PubMed Web of Science ®Google Scholar
• Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 1995, 9, 401–412.
   PubMedGoogle Scholar
• Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Jr. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol 1995, 15, 943–953.
   PubMed Web of Science ®Google Scholar
• Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, Adcock IM. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J Exp Med 2006, 203, 7–13.
   PubMed Web of Science ®Google Scholar